| Richard William Kendall, DO | |
|
50 N Medical Dr, Salt Lake City, UT 84132-0001 | |
| (801) 581-2267 | |
| Not Available |
| Full Name | Richard William Kendall |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 27 Years |
| Location | 50 N Medical Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508956103 | NPI | - | NPPES |
| 250013682 | Other | UT | RAILROAD MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2081P2900X | Physical Medicine & Rehabilitation - Pain Medicine | 5129934-1204 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Specialty Services | 2961726831 | 75 |
News Archive
Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.
An international research team including the University of Adelaide has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder.
Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
Federal legislation on health care reform and coverage expansion will have major impacts on cancer care. Community oncology professionals need to know how this legislation impacts them and their community practice. US Oncology, Inc., supporting the nation's foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to discover how this new legislation will impact cancer care in 2010.
› Verified 8 days ago
| Entity Name | University Of Utah Specialty Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043614811 PECOS PAC ID: 2961726831 Enrollment ID: O20150123002141 |
News Archive
Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.
An international research team including the University of Adelaide has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder.
Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
Federal legislation on health care reform and coverage expansion will have major impacts on cancer care. Community oncology professionals need to know how this legislation impacts them and their community practice. US Oncology, Inc., supporting the nation's foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to discover how this new legislation will impact cancer care in 2010.
› Verified 8 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.
An international research team including the University of Adelaide has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder.
Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
Federal legislation on health care reform and coverage expansion will have major impacts on cancer care. Community oncology professionals need to know how this legislation impacts them and their community practice. US Oncology, Inc., supporting the nation's foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to discover how this new legislation will impact cancer care in 2010.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Richard William Kendall, DO Po Box 413032, Salt Lake City, UT 84141-3032 Ph: (801) 213-3900 | Richard William Kendall, DO 50 N Medical Dr, Salt Lake City, UT 84132-0001 Ph: (801) 581-2267 |
News Archive
Dana-Farber Cancer Institute will establish the Riney Family Multiple Myeloma Initiative to help improve outcomes and accelerate understanding of the underlying biology for the most challenging types of myelomas, cancers that form in a type of white blood cell called a plasma cell.
An international research team including the University of Adelaide has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder.
Genentech, a member of the Roche Group and OSI Pharmaceuticals, a wholly owned subsidiary of Astellas U.S. Holding Inc., a holding company owned by Astellas Pharma Inc., today announced that an independent data monitoring committee has recommended that the Phase III EURTAC study be stopped early because the study met its primary endpoint.
MedPlexus today announced the creation of their "Cash for Clunkers" Program. The "stimulus package," which is available September 1, 2009, grants cash payments of $3,000 to $5,000 to doctors who replace their previous EHR and/or practice management platforms with MedPlexus integrated platforms.
Federal legislation on health care reform and coverage expansion will have major impacts on cancer care. Community oncology professionals need to know how this legislation impacts them and their community practice. US Oncology, Inc., supporting the nation's foremost cancer treatment and research network, announced today that it will host a complimentary educational webinar for community-based oncology practices to discover how this new legislation will impact cancer care in 2010.
› Verified 8 days ago
James Tran, MD Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: Rehab 85 N Medical Drive Rm 2122, Salt Lake City, UT 84132 Phone: 801-585-2589 | |
Dr. Chase K Hansen, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 1121 E Brickyard Rd Apt 1803, Salt Lake City, UT 84106 Phone: 801-309-0848 | |
Michael Tobler, Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 6360 S 3000 E Ste 300, Salt Lake City, UT 84121 Phone: 385-900-5094 | |
Dr. Jeffrey G Randle, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1160 E 3900 S, #5000, Salt Lake City, UT 84124 Phone: 801-262-8486 Fax: 801-284-8699 | |
Dr. Michael Matthew Green, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 81 N Mario Capecchi Dr, Department Of Pediatrics, Salt Lake City, UT 84113 Phone: 801-213-7737 Fax: 801-587-7539 | |
Ms. Allison Oki, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 50 N Medical Dr, Univerisity Of Utah, Department Of Pm&r, Salt Lake City, UT 84132 Phone: 801-585-2589 Fax: 801-587-7287 | |
Bradeigh Smithson Godfrey, D.O. Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 258 Heritage Ctr, Salt Lake City, UT 84112 Phone: 801-587-1290 |